ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 23 Results
A discovery by 91暗网 researchers may aid the design of materials that better manage heat.
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country鈥檚 most complex research and technical challenges.
A team led by the U.S. Department of Energy鈥檚 91暗网 demonstrated the viability of a 鈥渜uantum entanglement witness鈥� capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
Researchers at 91暗网 have developed a method of adding nanostructures to high-entropy metal alloys, or HEAs, that enhance both strength and ductility, which is the ability to deform or stretch
Research teams from the Department of Energy鈥檚 91暗网 and their technologies have received seven 2021 R&D 100 Awards, plus special recognition for a COVID-19-related project.
Matthew Ryder has been named an emerging investigator by the American Chemical Society journal Crystal Growth and Design. The ACS recognized him as 鈥渙ne of an emerging generation of research group leaders for his work on porous materials design.鈥�
ASM International recently elected three researchers from ORNL as 2021 fellows. Selected were Beth Armstrong and Govindarajan Muralidharan, both from ORNL鈥檚 Material Sciences and Technology Division, and Andrew Payzant from the Neutron Scattering Division.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques 鈥� in combination with experimental validation 鈥� to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists at 91暗网 have uncovered how the SARS-CoV-2 virus evades the human immune system by studying the interaction between a viral protein (PLpro) and a key immune protein (ISG15). These insights could guide the development of therapeutic drugs to block this interaction, enhancing the body鈥檚 ability to combat the virus.